http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 15 Aug 2025 11:12:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html si-local-file:///var/storage/secattach/20250815/25211899.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html Fri, 15 Aug 2025 11:12:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html si-local-file:///var/storage/secattach/20250815/25211899.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html Fri, 15 Aug 2025 11:12:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html si-local-file:///var/storage/secattach/20250815/25211899.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Aug+14/25211899.html Fri, 15 Aug 2025 11:12:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html si-local-file:///var/storage/secattach/20250815/25210238.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html Fri, 15 Aug 2025 06:05:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html si-local-file:///var/storage/secattach/20250815/25210238.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html Fri, 15 Aug 2025 06:05:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html si-local-file:///var/storage/secattach/20250815/25210238.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Jun+30/25210238.html Fri, 15 Aug 2025 06:05:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html si-local-file:///var/storage/secattach/20250520/24829746.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html Tue, 20 May 2025 17:30:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html si-local-file:///var/storage/secattach/20250520/24829746.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html Tue, 20 May 2025 17:30:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html si-local-file:///var/storage/secattach/20250520/24829746.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24829746.html Tue, 20 May 2025 17:30:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html si-local-file:///var/storage/secattach/20250515/24806023.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html Thu, 15 May 2025 14:16:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html si-local-file:///var/storage/secattach/20250515/24806023.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html Thu, 15 May 2025 14:16:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html si-local-file:///var/storage/secattach/20250515/24806023.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Sigyn+Therapeutics%2C+Inc.++For%3A+Mar+31/24806023.html Thu, 15 May 2025 14:16:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html si-local-file:///var/storage/secattach/20250415/24641665.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html Tue, 15 Apr 2025 13:43:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html si-local-file:///var/storage/secattach/20250415/24641665.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html Tue, 15 Apr 2025 13:43:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html si-local-file:///var/storage/secattach/20250415/24641665.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24641665.html Tue, 15 Apr 2025 13:43:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html si-local-file:///var/storage/secattach/20250331/24575187.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html Mon, 31 Mar 2025 16:24:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html si-local-file:///var/storage/secattach/20250331/24575187.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html Mon, 31 Mar 2025 16:24:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html si-local-file:///var/storage/secattach/20250331/24575187.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++Sigyn+Therapeutics%2C+Inc.++For%3A+Dec+31/24575187.html Mon, 31 Mar 2025 16:24:00 -0400 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html <p>SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (Sigyn or the Company) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. </p><p>Dear Reader, </p><p>Blood purification technologies have emerged to become leading post-exposure countermeasures to treat emerging pandemic viruses. When properly designed, these devices can also serve a dual-use purpose in everyday medicine. In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 end-stage renal disease (ESRD) patients who rely on http://www.streetinsider.com/Press+Releases/Sigyn+CEO+Note%3A+An+Emerging+New+Industry%2C+15+Years+in+the+Making/24488398.html Wed, 12 Mar 2025 08:00:00 -0400 0A3M A.17568957 A.23422451 O.04889877 O.07073414 O.21963843 O.37300898 SIGY SIGYD